These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26461941)

  • 21. Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
    Pontali E; Visca D; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Curr Opin Pulm Med; 2018 May; 24(3):244-252. PubMed ID: 29470252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Easier cure for resistant TB.
    Cohen J
    Science; 2017 Feb; 355(6326):677. PubMed ID: 28209851
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving the health of the tuberculosis drug pipeline.
    Burki T
    Lancet Infect Dis; 2014 Feb; 14(2):102-3. PubMed ID: 24605379
    [No Abstract]   [Full Text] [Related]  

  • 24. Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.
    Lessem E; Cox H; Daniels C; Furin J; McKenna L; Mitnick CD; Mosidi T; Reed C; Seaworth B; Stillo J; Tisile P; von Delft D
    Int J Infect Dis; 2015 Mar; 32():56-60. PubMed ID: 25809757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa.
    Master I; Furin J
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):985-7. PubMed ID: 27287655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.
    Bloemberg GV; Keller PM; Stucki D; Trauner A; Borrell S; Latshang T; Coscolla M; Rothe T; Hömke R; Ritter C; Feldmann J; Schulthess B; Gagneux S; Böttger EC
    N Engl J Med; 2015 Nov; 373(20):1986-8. PubMed ID: 26559594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel drugs against tuberculosis: a clinician's perspective.
    Olaru ID; von Groote-Bidlingmaier F; Heyckendorf J; Yew WW; Lange C; Chang KC
    Eur Respir J; 2015 Apr; 45(4):1119-31. PubMed ID: 25431273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
    Dheda K; Cox H; Esmail A; Wasserman S; Chang KC; Lange C
    Respirology; 2018 Jan; 23(1):36-45. PubMed ID: 28850767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
    Kuksa L; Barkane L; Hittel N; Gupta R
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29122917
    [No Abstract]   [Full Text] [Related]  

  • 30. Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany.
    Trauth J; Kantelhardt V; Usenko B; Knipper M; Kuhns M; Friesen I; Herold S
    Eur Respir J; 2024 May; 63(5):. PubMed ID: 38636988
    [No Abstract]   [Full Text] [Related]  

  • 31. Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.
    Alffenaar JC; Akkerman OW; Anthony RM; Tiberi S; Heysell S; Grobusch MP; Cobelens FG; Van Soolingen D
    Expert Rev Anti Infect Ther; 2017 Jan; 15(1):11-21. PubMed ID: 27762157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.
    Silva DR; Dalcolmo M; Tiberi S; Arbex MA; Munoz-Torrico M; Duarte R; D'Ambrosio L; Visca D; Rendon A; Gaga M; Zumla A; Migliori GB
    J Bras Pneumol; 2018 Apr; 44(2):153-160. PubMed ID: 29791557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use.
    Tiberi S; De Lorenzo S; Centis R; Viggiani P; D'Ambrosio L; Migliori GB
    Eur Respir J; 2014 Jan; 43(1):289-92. PubMed ID: 23988772
    [No Abstract]   [Full Text] [Related]  

  • 34. Landmark legal ruling sees Indian girl prescribed bedaquiline for XDR-TB.
    Kirby T
    Lancet Respir Med; 2017 Apr; 5(4):249. PubMed ID: 28169199
    [No Abstract]   [Full Text] [Related]  

  • 35. Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB.
    Danckers M; Lesko MB; Adamson R; Leibert E
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1522-3. PubMed ID: 25517823
    [No Abstract]   [Full Text] [Related]  

  • 36. Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
    Cox V; Brigden G; Crespo RH; Lessem E; Lynch S; Rich ML; Waning B; Furin J
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):407-412. PubMed ID: 29562988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bedaquiline and delamanid in tuberculosis.
    Esposito S; Bianchini S; Blasi F
    Expert Opin Pharmacother; 2015; 16(15):2319-30. PubMed ID: 26293803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients.
    Acquah R; Mohr-Holland E; Daniels J; Furin J; Loveday M; Mudaly V; Reuter A
    Pediatr Infect Dis J; 2021 May; 40(5):e191-e192. PubMed ID: 33847295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The STREAM trial: missed opportunities and lessons for future clinical trials.
    Loveday M; Reuter A; Furin J; Seddon JA; Cox H
    Lancet Infect Dis; 2019 Apr; 19(4):351-353. PubMed ID: 30910428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.